Pfizer (PFE) Other Operating Expenses (2010 - 2017)

Pfizer (PFE) has 8 years of Other Operating Expenses data on file, last reported at -$6.7 billion in Q4 2017.

• Other Operating Expenses for Q4 2017 came in at -$6.7 billion, up 12.65% year-over-year; the trailing twelve-month figure through Sep 2018 was -$6.7 billion (up 71.67% YoY), and the FY2017 annual result was -$22.7 billion, up 6.78% from the prior year.
• Other Operating Expenses eased to -$6.7 billion in Q4 2017 per PFE's latest filing, from -$5.4 billion in the prior quarter.
• Over five years, Other Operating Expenses peaked at $1.1 billion in Q2 2013 and troughed at -$7.9 billion in Q4 2015.
• A 5-year average of -$3.9 billion and a median of -$5.3 billion in 2017 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2013 and 2015: Other Operating Expenses soared 255.52% in 2013, then sank 9796.23% in 2015.
• A 5-year view of Other Operating Expenses shows it stood at $18.0 million in 2013, then jumped by 194.44% to $53.0 million in 2014, then tumbled by 14983.02% to -$7.9 billion in 2015, then increased by 2.69% to -$7.7 billion in 2016, then increased by 12.65% to -$6.7 billion in 2017.
• Business Quant data shows PFE's Other Operating Expenses at -$6.7 billion in Q4 2017, -$5.4 billion in Q4 2017, and -$5.3 billion in Q3 2017.